BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36646436)

  • 1. Pathological spectrum of hereditary transthyretin renal amyloidosis and clinicopathologic correlation: a French observational study.
    Dang J; Ferlicot S; Misrahi M; Mussini C; Kounis I; Rémy P; Samuel D; Planté-Bordeneuve V; Adams D; Funalot B; Snanoudj R; Damy T; Moktefi A; Audard V; Zaidan M
    Nephrol Dial Transplant; 2023 Aug; 38(9):2019-2030. PubMed ID: 36646436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural course and determinants of short-term kidney function decline in hereditary transthyretin amyloidosis: a French observational study.
    Dang J; Segaux L; Moktefi A; Stehlé T; Kharoubi M; El Karoui K; Rémy P; Grimbert P; Plante-Bordeneuve V; Guendouz S; Galat A; Mallet S; Oghina S; Chadha GDS; Zaroui A; Fanen P; Canoui-Poitrine F; Damy T; Audard V
    Amyloid; 2023 Mar; 30(1):38-48. PubMed ID: 35848215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypes Associated With the Val122Ile, Leu58His, and Late-Onset Val30Met Variants in Patients With Hereditary Transthyretin Amyloidosis.
    Zampino S; Sheikh FH; Vaishnav J; Judge D; Pan B; Daniel A; Brown E; Ebenezer G; Polydefkis M
    Neurology; 2023 May; 100(19):e2036-e2044. PubMed ID: 36941075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study.
    Albenque G; Bézard M; Kharoubi M; Odouard S; Lunati A; Poullot E; Zaroui A; Teiger E; Hittinger L; Audard V; El Karoui K; Funalot B; Fanen P; Damy T; Oghina S
    Amyloid; 2023 Dec; 30(4):407-415. PubMed ID: 37377439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
    Louwsma J; Brunger AF; Bijzet J; Kroesen BJ; Roeloffzen WWH; Bischof A; Kuhle J; Drost G; Lange F; Kuks JBM; Gans ROB; Hazenberg BPC; Nienhuis HLA
    Amyloid; 2021 Mar; 28(1):50-55. PubMed ID: 32883119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
    Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
    Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Patterns of Amyloid Pathology in Autopsies of Transthyretin S77Y and A97S Amyloidosis: Significance of Symptomatology and Cell Biology.
    Chang K; Yang WK; Li WT; Yeh TY; Jao CH; Lin JR; Lin CC; Jeng YM; Chao CC; Hsieh ST
    J Neuropathol Exp Neurol; 2022 Apr; 81(5):363-376. PubMed ID: 35388433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Gentile L; Diemberger I; Plante-Bordeneuve V; Mazzeo A; Dori A; Luigetti M; Di Paolantonio A; Dispenzieri A; Grogan M; Waddington Cruz M; Adams D; Inamo J; Kristen AV; Lino Cirami C; Chapman D; Gupta P; Glass O; Amass L
    PLoS One; 2024; 19(1):e0292435. PubMed ID: 38241252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin amyloidosis and the kidney.
    Lobato L; Rocha A
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1337-46. PubMed ID: 22537653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
    Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
    Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
    Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary transthyretin amyloidosis overview.
    Manganelli F; Fabrizi GM; Luigetti M; Mandich P; Mazzeo A; Pareyson D
    Neurol Sci; 2022 Dec; 43(Suppl 2):595-604. PubMed ID: 33188616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive Patterns of Transthyretin Amyloid in Salivary Tissue: A Clinicopathologic Study of 92 Patients With Amyloid-containing Minor Salivary Gland Biopsies.
    Jamet MP; Gnemmi V; Hachulla É; Dhaenens CM; Bouchindhomme B; Delattre C; Glowacki F; Hatron PY; Lacour A; Lamblin N; Launay D; Leleu X; Guiochon-Mantel A; Valleix S; Maurage CA; Copin MC; Buob D
    Am J Surg Pathol; 2015 Aug; 39(8):1035-44. PubMed ID: 25828388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNS Involvement in Hereditary Transthyretin Amyloidosis.
    Sousa L; Coelho T; Taipa R
    Neurology; 2021 Dec; 97(24):1111-1119. PubMed ID: 34663645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M).
    Lobato L
    J Nephrol; 2003; 16(3):438-42. PubMed ID: 12832749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study.
    Fargeot G; Echaniz-Laguna A; Labeyrie C; Svahn J; Camdessanché JP; Cintas P; Chanson JB; Esselin F; Piedvache C; Verstuyft C; Genestet S; Lagrange E; Magy L; Péréon Y; Sacconi S; Signate A; Nadaj-Pakleza A; Taithe F; Viala K; Tard C; Poinsignon V; Cauquil C; Attarian S; Adams D
    Amyloid; 2024 Mar; 31(1):62-69. PubMed ID: 37855400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary Transthyretin Amyloidosis- Clinical and Genetic Characteristics of a Multiracial South-East Asian Cohort in Singapore.
    Chen Z; Koh JS; Saini M; Tay KSS; Jayne Tan Y; Chai JYH; Fam SR; Juraidah AR; Lim PK; Ng ASL; Prasad K; Tan CB; Umapathi T; Verma KK; Yong MH; Yu C; Ng PS
    J Neuromuscul Dis; 2021; 8(4):723-733. PubMed ID: 34024775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology of central nervous system involvement in TTR amyloidosis.
    Taipa R; Sousa L; Pinto M; Reis I; Rodrigues A; Oliveira P; Melo-Pires M; Coelho T
    Acta Neuropathol; 2023 Jan; 145(1):113-126. PubMed ID: 36198883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.